Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO7513 | Cannabis sativa | Species | Cannabaceae | Eukaryota |
PMID[18681481] |
|||
NPO7513 | Cannabis sativa | Species | Cannabaceae | Eukaryota | TCMSP* | |||
NPO7513 | Cannabis sativa | Species | Cannabaceae | Eukaryota | HerDing* | |||
NPO7513 | Cannabis sativa | Species | Cannabaceae | Eukaryota | Aerial parts |
PMID[21902175] |
||
NPO7513.1 | Cannabis sativa var. indica | Varieties | Cannabaceae | Eukaryota | HerDing* | |||
NPO7513 | Cannabis sativa | Species | Cannabaceae | Eukaryota | TCMID* | |||
NPO7513.1 | Cannabis sativa var. indica | Varieties | Cannabaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | IC50 | = | 5.8 | nM | 7636873 |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 4 | nM | 7636873 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.006 | mg/kg | 8057304 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.415 | mg/kg | 8057304 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.51 | mg/kg | 8057304 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 3.2 | mg/kg | 2989518 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | IC50 | = | 5.8 | nM | 10.1016/0960-894X(95)00560-G |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 4 | nM | 10.1016/0960-894X(95)00560-G |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 47.6 | nM | 8809166 |
NPT1169 | Individual Protein | Cannabinoid CB2 receptor | Mus musculus | Ki | = | 39.3 | nM | 8809166 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 41 | nM | 9784115 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1 | mg/kg | 9784115 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.4 | mg/kg | 9784115 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.5 | mg/kg | 9784115 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 59 | 6296389 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 20 | 6296389 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 17 | 6296389 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 6 | 6296389 | |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1 | mg/kg | 1659638 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.4 | mg/kg | 1659638 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.5 | mg/kg | 1659638 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.6 | mg/kg | 1659638 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | IC50 | = | 218 | nM | 1659638 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 41 | nM | 9357528 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1 | mg/kg | 9357528 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.4 | mg/kg | 9357528 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.5 | mg/kg | 9357528 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 66.5 | nM | 9379442 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 80.3 | nM | 9379442 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 32.2 | nM | 9379442 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | EC50 | = | 11 | nM | 9379442 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Inhibition | = | 21 | % | 9379442 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 27 | mg/kg | 6681843 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 43 | mg/kg | 6681843 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 41 | nM | 11020293 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 11020293 |
NPT736 | Organism | Columba livia | Columba livia | ED50 | = | 0.16 | mg/kg | 1317925 |
NPT736 | Organism | Columba livia | Columba livia | ED50 | = | 0.25 | mg/kg | 1317925 |
NPT736 | Organism | Columba livia | Columba livia | ED50 | = | 1.21 | mg/kg | 1317925 |
NPT4118 | Protein Family | Cannabinoid receptor | Rattus norvegicus | Ki | = | 46 | nM | 1317925 |
NPT1362 | Protein Family | Cannabinoid receptor | Homo sapiens | Ki | = | 41 | nM | 10.1016/S0960-894X(01)80155-4 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 4.7 | umol/kg | 10.1016/S0960-894X(01)80155-4 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.66 | mg/kg | 2155318 |
NPT736 | Organism | Columba livia | Columba livia | ED50 | = | 0.18 | mg/kg | 2155318 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 28.5 | nM | 14505654 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 25 | nM | 14505654 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ratio | = | 1.14 | 14505654 | |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 41 | nM | 8831752 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 8831752 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 2.9 | umol/kg | 8831752 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 4.8 | umol/kg | 8831752 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 4.5 | umol/kg | 8831752 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 41 | nM | 16005223 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 16005223 |
NPT2 | Others | Unspecified | Ratio | = | 1.1 | 16005223 | ||
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 37 | nM | 16078824 |
NPT2 | Others | Unspecified | Ki | = | 20 | nM | 16078824 | |
NPT1363 | Individual Protein | Anandamide amidohydrolase | Mus musculus | Inhibition | = | 31 | % | 16078824 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | EC50 | = | 199.53 | nM | 16420041 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1 | mg/kg | 17257842 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.4 | mg/kg | 17257842 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 29 | ug | 17257842 |
NPT1169 | Individual Protein | Cannabinoid CB2 receptor | Mus musculus | Ki | = | 9.2 | nM | 17531479 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 40 | nM | 17531479 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 3.3 | nM | 17531479 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 17 | nM | 17531479 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.4 | mg/kg | 17531479 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.3 | mg/kg | 17531479 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 41 | nM | 17919913 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 17919913 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1.1 | 17919913 | ||
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2 | ug/ml | 18681481 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1 | ug/ml | 18681481 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 0.5 | ug/ml | 18681481 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 41 | nM | 18522867 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 2.9 | nM | 18522867 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 1.5 | nM | 18522867 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 40 | nM | 20079638 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 20079638 |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | EC50 | = | 230 | nM | 20356305 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 20621488 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 41 | nM | 20621488 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1.1 | 20621488 | ||
NPT346 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Homo sapiens | Activity | = | 0.01 | nM | 16408004 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1.1 | 20943404 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 20943404 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 41 | nM | 20943404 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | IC50 | = | 2.8 | nM | 21999614 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | IC50 | = | 9.5 | nM | 21999614 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 10 | nM | 22284817 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 17 | nM | 22284817 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 24 | nM | 22284817 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 4.8 | umol/kg | 22341572 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 4.5 | umol/kg | 22341572 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 3.2 | umol/kg | 22341572 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 41 | nM | 22341572 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36 | nM | 22341572 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1.1 | 22341572 | ||
NPT2 | Others | Unspecified | Potency | 26608.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21136 | nM | PubChem BioAssay data set | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 71.6 | nM | 23679955 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 3.88 | nM | 23679955 |
NPT4119 | Individual Protein | N-arachidonyl glycine receptor | Homo sapiens | EC50 | = | 4610 | nM | 23679955 |
NPT4120 | Individual Protein | G-protein coupled receptor 55 | Homo sapiens | IC50 | = | 14200 | nM | 23679955 |
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23710.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23914.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3757.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16785.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30106.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18995.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10590.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT4119 | Individual Protein | N-arachidonyl glycine receptor | Homo sapiens | EC50 | = | 4610 | nM | 10.1039/C3MD00394A |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 71.6 | nM | 10.1039/C3MD00394A |
NPT4119 | Individual Protein | N-arachidonyl glycine receptor | Homo sapiens | EC50 | = | 960 | nM | 10.1039/C3MD00394A |
NPT4120 | Individual Protein | G-protein coupled receptor 55 | Homo sapiens | EC50 | = | 14200 | nM | 10.1039/C3MD00394A |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 3.88 | nM | 10.1039/C3MD00394A |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.02 | mg/kg | 23865723 |
NPT2 | Others | Unspecified | Ratio Ki | = | 1.1 | 23865723 | ||
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 36.4 | nM | 23865723 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 40.7 | nM | 23865723 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.062 | mg/kg | 691006 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | > | 100 | mg/kg | 691006 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 43 | mg/kg | 691006 |
NPT2 | Others | Unspecified | Ki | = | 302 | nM | 722729 | |
NPT2 | Others | Unspecified | Ratio Ki | = | 100 | 722729 | ||
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 39.5 | nM | 24900848 |
NPT1169 | Individual Protein | Cannabinoid CB2 receptor | Mus musculus | Ki | = | 40 | nM | 24900848 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 15 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 41 | % | 817021 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 20 | mg/kg | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 39 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 21 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 6 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 8 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.7 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 7.5 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 7.3 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 8.2 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 8.9 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 0 | % | 817021 |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | >= | 1000 | mg/kg | 817021 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 9.6 | mg/kg | 966252 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 27.2 | mg/kg | 915915 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 43 | mg/kg | 915915 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 36 | % | 915915 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 39 | % | 915915 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 4 | mg/kg | 915915 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 15 | % | 915915 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 27.2 | mg/kg | 817021 |
NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 43 | mg/kg | 817021 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 68 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 14 | % | 817021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 72 | % | 817021 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 22 | nM | 25072877 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 46 | nM | 25072877 |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | EC50 | = | 12.3 | nM | 25072877 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | EC50 | = | 77.5 | nM | 25072877 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 5000 | nM | 25671648 |
NPT426 | Individual Protein | Glycine receptor subunit alpha-1 | Homo sapiens | Activity | = | 162 | % | 25790278 |
NPT426 | Individual Protein | Glycine receptor subunit alpha-1 | Homo sapiens | EC50 | = | 1300 | nM | 25790278 |
NPT1170 | Individual Protein | Cannabinoid CB1 receptor | Mus musculus | Ki | = | 15.3 | nM | 22904561 |
NPT543 | Individual Protein | Pregnane X receptor | Homo sapiens | EC50 | = | 31600 | nM | 20966043 |
NPT543 | Individual Protein | Pregnane X receptor | Homo sapiens | EC50 | = | 12600 | nM | 20966043 |
NPT2 | Others | Unspecified | Potency | 21313.8 | nM | PubChem BioAssay data set | ||
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 194 | 26000707 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 276.2 | 26000707 | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 190.9 | 26000707 | |
NPT1287 | Individual Protein | Cannabinoid CB2 receptor | Homo sapiens | Ki | = | 42 | nM | 26000707 |
NPT232 | Individual Protein | Cannabinoid CB1 receptor | Homo sapiens | Ki | = | 18 | nM | 26000707 |
NPT1361 | Individual Protein | Cannabinoid CB1 receptor | Rattus norvegicus | Ki | = | 36 | nM | 26890113 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC96940 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9587 | High Similarity | NPC38604 |
0.9587 | High Similarity | NPC211179 |
0.9508 | High Similarity | NPC472796 |
0.9508 | High Similarity | NPC472795 |
0.9407 | High Similarity | NPC218753 |
0.935 | High Similarity | NPC222108 |
0.935 | High Similarity | NPC472797 |
0.935 | High Similarity | NPC96719 |
0.9237 | High Similarity | NPC137294 |
0.9237 | High Similarity | NPC85895 |
0.9194 | High Similarity | NPC16577 |
0.9187 | High Similarity | NPC46978 |
0.9127 | High Similarity | NPC472798 |
0.9048 | High Similarity | NPC472590 |
0.9048 | High Similarity | NPC160623 |
0.9032 | High Similarity | NPC473134 |
0.9024 | High Similarity | NPC476254 |
0.9024 | High Similarity | NPC131397 |
0.9008 | High Similarity | NPC212965 |
0.8976 | High Similarity | NPC469611 |
0.8943 | High Similarity | NPC270030 |
0.8934 | High Similarity | NPC74137 |
0.8934 | High Similarity | NPC120638 |
0.8917 | High Similarity | NPC51341 |
0.8917 | High Similarity | NPC184302 |
0.8906 | High Similarity | NPC469610 |
0.8898 | High Similarity | NPC8899 |
0.8846 | High Similarity | NPC472800 |
0.8833 | High Similarity | NPC190514 |
0.88 | High Similarity | NPC283049 |
0.88 | High Similarity | NPC26879 |
0.88 | High Similarity | NPC230479 |
0.88 | High Similarity | NPC50315 |
0.875 | High Similarity | NPC33270 |
0.875 | High Similarity | NPC69261 |
0.872 | High Similarity | NPC293801 |
0.8707 | High Similarity | NPC186385 |
0.8707 | High Similarity | NPC299568 |
0.8699 | High Similarity | NPC54972 |
0.8699 | High Similarity | NPC193364 |
0.8667 | High Similarity | NPC150624 |
0.8661 | High Similarity | NPC38664 |
0.8661 | High Similarity | NPC53986 |
0.8632 | High Similarity | NPC168657 |
0.8629 | High Similarity | NPC77789 |
0.8629 | High Similarity | NPC36016 |
0.8629 | High Similarity | NPC100099 |
0.8629 | High Similarity | NPC18128 |
0.8605 | High Similarity | NPC118683 |
0.8605 | High Similarity | NPC244888 |
0.8605 | High Similarity | NPC164804 |
0.8605 | High Similarity | NPC293203 |
0.8605 | High Similarity | NPC68205 |
0.8605 | High Similarity | NPC211413 |
0.8605 | High Similarity | NPC469907 |
0.8595 | High Similarity | NPC244816 |
0.8595 | High Similarity | NPC50521 |
0.8595 | High Similarity | NPC221549 |
0.8594 | High Similarity | NPC93962 |
0.8583 | High Similarity | NPC53906 |
0.8583 | High Similarity | NPC808 |
0.8582 | High Similarity | NPC71046 |
0.8571 | High Similarity | NPC105031 |
0.8561 | High Similarity | NPC327735 |
0.8561 | High Similarity | NPC126101 |
0.856 | High Similarity | NPC261992 |
0.856 | High Similarity | NPC76465 |
0.856 | High Similarity | NPC38761 |
0.8559 | High Similarity | NPC255068 |
0.855 | High Similarity | NPC473107 |
0.8548 | High Similarity | NPC168707 |
0.8548 | High Similarity | NPC48623 |
0.8538 | High Similarity | NPC13005 |
0.8527 | High Similarity | NPC474481 |
0.8527 | High Similarity | NPC470225 |
0.8527 | High Similarity | NPC27187 |
0.8516 | High Similarity | NPC47283 |
0.8516 | High Similarity | NPC39064 |
0.8512 | High Similarity | NPC114064 |
0.8504 | High Similarity | NPC82299 |
0.8504 | High Similarity | NPC170485 |
0.85 | High Similarity | NPC22610 |
0.85 | High Similarity | NPC276737 |
0.8496 | Intermediate Similarity | NPC35550 |
0.8492 | Intermediate Similarity | NPC86502 |
0.8492 | Intermediate Similarity | NPC197351 |
0.8492 | Intermediate Similarity | NPC106914 |
0.8492 | Intermediate Similarity | NPC134195 |
0.8492 | Intermediate Similarity | NPC246648 |
0.8485 | Intermediate Similarity | NPC327382 |
0.848 | Intermediate Similarity | NPC57199 |
0.848 | Intermediate Similarity | NPC188997 |
0.8473 | Intermediate Similarity | NPC77196 |
0.8473 | Intermediate Similarity | NPC24913 |
0.8473 | Intermediate Similarity | NPC177712 |
0.8468 | Intermediate Similarity | NPC96423 |
0.8468 | Intermediate Similarity | NPC102639 |
0.8468 | Intermediate Similarity | NPC45663 |
0.8462 | Intermediate Similarity | NPC164574 |
0.8462 | Intermediate Similarity | NPC300875 |
0.8462 | Intermediate Similarity | NPC280653 |
0.8462 | Intermediate Similarity | NPC476166 |
0.8462 | Intermediate Similarity | NPC17343 |
0.8462 | Intermediate Similarity | NPC207892 |
0.8462 | Intermediate Similarity | NPC471517 |
0.8462 | Intermediate Similarity | NPC181497 |
0.8462 | Intermediate Similarity | NPC150011 |
0.8462 | Intermediate Similarity | NPC129106 |
0.8462 | Intermediate Similarity | NPC271945 |
0.8462 | Intermediate Similarity | NPC236014 |
0.8462 | Intermediate Similarity | NPC268917 |
0.8462 | Intermediate Similarity | NPC118114 |
0.8462 | Intermediate Similarity | NPC129784 |
0.8462 | Intermediate Similarity | NPC162801 |
0.8462 | Intermediate Similarity | NPC196765 |
0.8462 | Intermediate Similarity | NPC12875 |
0.8462 | Intermediate Similarity | NPC206224 |
0.8462 | Intermediate Similarity | NPC228369 |
0.8455 | Intermediate Similarity | NPC471449 |
0.8443 | Intermediate Similarity | NPC470759 |
0.8443 | Intermediate Similarity | NPC15860 |
0.8443 | Intermediate Similarity | NPC187993 |
0.8443 | Intermediate Similarity | NPC474933 |
0.8443 | Intermediate Similarity | NPC238176 |
0.8443 | Intermediate Similarity | NPC127894 |
0.8443 | Intermediate Similarity | NPC219070 |
0.8438 | Intermediate Similarity | NPC473221 |
0.8438 | Intermediate Similarity | NPC149796 |
0.843 | Intermediate Similarity | NPC167934 |
0.8425 | Intermediate Similarity | NPC103420 |
0.8425 | Intermediate Similarity | NPC285040 |
0.8425 | Intermediate Similarity | NPC188022 |
0.8425 | Intermediate Similarity | NPC113495 |
0.8425 | Intermediate Similarity | NPC17809 |
0.8425 | Intermediate Similarity | NPC102540 |
0.8421 | Intermediate Similarity | NPC270456 |
0.8421 | Intermediate Similarity | NPC248727 |
0.8421 | Intermediate Similarity | NPC162659 |
0.8421 | Intermediate Similarity | NPC173660 |
0.8421 | Intermediate Similarity | NPC265433 |
0.8421 | Intermediate Similarity | NPC141717 |
0.8417 | Intermediate Similarity | NPC319803 |
0.8409 | Intermediate Similarity | NPC225696 |
0.8409 | Intermediate Similarity | NPC223008 |
0.8409 | Intermediate Similarity | NPC97834 |
0.8409 | Intermediate Similarity | NPC198154 |
0.8409 | Intermediate Similarity | NPC115335 |
0.8409 | Intermediate Similarity | NPC317380 |
0.8409 | Intermediate Similarity | NPC296915 |
0.8403 | Intermediate Similarity | NPC224527 |
0.84 | Intermediate Similarity | NPC476633 |
0.8397 | Intermediate Similarity | NPC127624 |
0.8394 | Intermediate Similarity | NPC469795 |
0.8387 | Intermediate Similarity | NPC8283 |
0.8387 | Intermediate Similarity | NPC258979 |
0.8387 | Intermediate Similarity | NPC93398 |
0.8372 | Intermediate Similarity | NPC222572 |
0.8372 | Intermediate Similarity | NPC274717 |
0.8372 | Intermediate Similarity | NPC215300 |
0.8372 | Intermediate Similarity | NPC87224 |
0.8362 | Intermediate Similarity | NPC37802 |
0.8361 | Intermediate Similarity | NPC85292 |
0.8361 | Intermediate Similarity | NPC69539 |
0.8361 | Intermediate Similarity | NPC54507 |
0.8361 | Intermediate Similarity | NPC141090 |
0.8361 | Intermediate Similarity | NPC229147 |
0.8359 | Intermediate Similarity | NPC476006 |
0.8359 | Intermediate Similarity | NPC276212 |
0.8359 | Intermediate Similarity | NPC471215 |
0.8359 | Intermediate Similarity | NPC245060 |
0.8359 | Intermediate Similarity | NPC262573 |
0.8358 | Intermediate Similarity | NPC134260 |
0.8346 | Intermediate Similarity | NPC138248 |
0.8346 | Intermediate Similarity | NPC248557 |
0.8346 | Intermediate Similarity | NPC61685 |
0.8346 | Intermediate Similarity | NPC159132 |
0.8346 | Intermediate Similarity | NPC151224 |
0.8346 | Intermediate Similarity | NPC140521 |
0.8346 | Intermediate Similarity | NPC228503 |
0.8346 | Intermediate Similarity | NPC78446 |
0.8346 | Intermediate Similarity | NPC195022 |
0.8333 | Intermediate Similarity | NPC92805 |
0.8333 | Intermediate Similarity | NPC85435 |
0.8333 | Intermediate Similarity | NPC269528 |
0.8333 | Intermediate Similarity | NPC36661 |
0.8333 | Intermediate Similarity | NPC11060 |
0.8333 | Intermediate Similarity | NPC469557 |
0.8321 | Intermediate Similarity | NPC82503 |
0.8309 | Intermediate Similarity | NPC265075 |
0.8308 | Intermediate Similarity | NPC471518 |
0.8308 | Intermediate Similarity | NPC134360 |
0.8308 | Intermediate Similarity | NPC471519 |
0.8306 | Intermediate Similarity | NPC295259 |
0.8296 | Intermediate Similarity | NPC25966 |
0.8296 | Intermediate Similarity | NPC70682 |
0.8296 | Intermediate Similarity | NPC127218 |
0.8296 | Intermediate Similarity | NPC260741 |
0.8296 | Intermediate Similarity | NPC471388 |
0.8296 | Intermediate Similarity | NPC319647 |
0.8296 | Intermediate Similarity | NPC245207 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC96940 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD4749 | Approved |
0.9431 | High Similarity | NPD6410 | Clinical (unspecified phase) |
0.9194 | High Similarity | NPD4625 | Phase 3 |
0.8779 | High Similarity | NPD6099 | Approved |
0.8779 | High Similarity | NPD6100 | Approved |
0.8707 | High Similarity | NPD4750 | Phase 3 |
0.8699 | High Similarity | NPD1610 | Phase 2 |
0.8661 | High Similarity | NPD4908 | Phase 1 |
0.8657 | High Similarity | NPD6398 | Clinical (unspecified phase) |
0.8651 | High Similarity | NPD6917 | Clinical (unspecified phase) |
0.8527 | High Similarity | NPD4907 | Clinical (unspecified phase) |
0.843 | Intermediate Similarity | NPD6671 | Approved |
0.8295 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8231 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8226 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8203 | Intermediate Similarity | NPD6696 | Suspended |
0.8154 | Intermediate Similarity | NPD2861 | Phase 2 |
0.8065 | Intermediate Similarity | NPD7340 | Approved |
0.7985 | Intermediate Similarity | NPD1613 | Approved |
0.7985 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7969 | Intermediate Similarity | NPD422 | Phase 1 |
0.7967 | Intermediate Similarity | NPD1398 | Phase 1 |
0.7692 | Intermediate Similarity | NPD7837 | Clinical (unspecified phase) |
0.7664 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7664 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD940 | Approved |
0.7647 | Intermediate Similarity | NPD846 | Approved |
0.763 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7607 | Intermediate Similarity | NPD288 | Approved |
0.7594 | Intermediate Similarity | NPD2797 | Approved |
0.7538 | Intermediate Similarity | NPD1778 | Approved |
0.7535 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7521 | Intermediate Similarity | NPD844 | Approved |
0.7517 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1608 | Approved |
0.7483 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7483 | Intermediate Similarity | NPD3750 | Approved |
0.7445 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7444 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7429 | Intermediate Similarity | NPD2200 | Suspended |
0.7424 | Intermediate Similarity | NPD1091 | Approved |
0.7405 | Intermediate Similarity | NPD4626 | Approved |
0.7397 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7388 | Intermediate Similarity | NPD8651 | Approved |
0.7368 | Intermediate Similarity | NPD2230 | Approved |
0.7368 | Intermediate Similarity | NPD2232 | Approved |
0.7368 | Intermediate Similarity | NPD2233 | Approved |
0.7361 | Intermediate Similarity | NPD7466 | Approved |
0.7357 | Intermediate Similarity | NPD4097 | Suspended |
0.7343 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7339 | Intermediate Similarity | NPD290 | Approved |
0.7338 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7338 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7329 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7329 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7319 | Intermediate Similarity | NPD3268 | Approved |
0.7308 | Intermediate Similarity | NPD7644 | Approved |
0.728 | Intermediate Similarity | NPD2684 | Approved |
0.7279 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7279 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD17 | Approved |
0.7273 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7258 | Intermediate Similarity | NPD968 | Approved |
0.7237 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD1607 | Approved |
0.7226 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7222 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7218 | Intermediate Similarity | NPD3496 | Discontinued |
0.7203 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7197 | Intermediate Similarity | NPD5691 | Approved |
0.719 | Intermediate Similarity | NPD3020 | Approved |
0.719 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7188 | Intermediate Similarity | NPD7635 | Approved |
0.7185 | Intermediate Similarity | NPD5327 | Phase 3 |
0.7179 | Intermediate Similarity | NPD6959 | Discontinued |
0.7172 | Intermediate Similarity | NPD6674 | Discontinued |
0.7171 | Intermediate Similarity | NPD1934 | Approved |
0.7164 | Intermediate Similarity | NPD1611 | Approved |
0.7163 | Intermediate Similarity | NPD5735 | Approved |
0.7162 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD7157 | Approved |
0.7153 | Intermediate Similarity | NPD5762 | Approved |
0.7153 | Intermediate Similarity | NPD5763 | Approved |
0.7153 | Intermediate Similarity | NPD4624 | Approved |
0.7133 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7133 | Intermediate Similarity | NPD3748 | Approved |
0.7133 | Intermediate Similarity | NPD7033 | Discontinued |
0.7132 | Intermediate Similarity | NPD3225 | Approved |
0.7132 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7131 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD7819 | Suspended |
0.7122 | Intermediate Similarity | NPD7095 | Approved |
0.7113 | Intermediate Similarity | NPD6353 | Approved |
0.7111 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7111 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7109 | Intermediate Similarity | NPD228 | Approved |
0.7101 | Intermediate Similarity | NPD1712 | Approved |
0.7101 | Intermediate Similarity | NPD2237 | Approved |
0.7095 | Intermediate Similarity | NPD1511 | Approved |
0.7092 | Intermediate Similarity | NPD1240 | Approved |
0.7092 | Intermediate Similarity | NPD4140 | Approved |
0.7083 | Intermediate Similarity | NPD2796 | Approved |
0.7063 | Intermediate Similarity | NPD2342 | Discontinued |
0.7059 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7059 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7059 | Intermediate Similarity | NPD845 | Approved |
0.7059 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7059 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7055 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7055 | Intermediate Similarity | NPD2800 | Approved |
0.7054 | Intermediate Similarity | NPD5535 | Approved |
0.7054 | Intermediate Similarity | NPD7843 | Approved |
0.7047 | Intermediate Similarity | NPD2534 | Approved |
0.7047 | Intermediate Similarity | NPD2532 | Approved |
0.7047 | Intermediate Similarity | NPD2533 | Approved |
0.7032 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD709 | Approved |
0.702 | Intermediate Similarity | NPD1653 | Approved |
0.7015 | Intermediate Similarity | NPD2667 | Approved |
0.7015 | Intermediate Similarity | NPD2668 | Approved |
0.7014 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7013 | Intermediate Similarity | NPD2801 | Approved |
0.7 | Intermediate Similarity | NPD1512 | Approved |
0.6993 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6985 | Remote Similarity | NPD2981 | Phase 2 |
0.6974 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6972 | Remote Similarity | NPD3619 | Clinical (unspecified phase) |
0.6972 | Remote Similarity | NPD3620 | Phase 2 |
0.6957 | Remote Similarity | NPD3266 | Approved |
0.6957 | Remote Similarity | NPD3267 | Approved |
0.6953 | Remote Similarity | NPD3022 | Approved |
0.6953 | Remote Similarity | NPD3021 | Approved |
0.6948 | Remote Similarity | NPD37 | Approved |
0.6943 | Remote Similarity | NPD6234 | Discontinued |
0.6942 | Remote Similarity | NPD2859 | Approved |
0.6942 | Remote Similarity | NPD2860 | Approved |
0.694 | Remote Similarity | NPD3445 | Approved |
0.694 | Remote Similarity | NPD3443 | Approved |
0.694 | Remote Similarity | NPD5585 | Approved |
0.694 | Remote Similarity | NPD3444 | Approved |
0.6929 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD4966 | Approved |
0.6923 | Remote Similarity | NPD7768 | Phase 2 |
0.6923 | Remote Similarity | NPD4967 | Phase 2 |
0.6923 | Remote Similarity | NPD4965 | Approved |
0.6923 | Remote Similarity | NPD821 | Approved |
0.6918 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD6005 | Phase 3 |
0.6918 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD6004 | Phase 3 |
0.6918 | Remote Similarity | NPD2346 | Discontinued |
0.6918 | Remote Similarity | NPD6002 | Phase 3 |
0.6914 | Remote Similarity | NPD5844 | Phase 1 |
0.6913 | Remote Similarity | NPD6815 | Approved |
0.6906 | Remote Similarity | NPD3690 | Phase 2 |
0.6906 | Remote Similarity | NPD3691 | Phase 2 |
0.6899 | Remote Similarity | NPD6746 | Phase 2 |
0.6894 | Remote Similarity | NPD2557 | Approved |
0.6887 | Remote Similarity | NPD6090 | Discontinued |
0.6884 | Remote Similarity | NPD1283 | Approved |
0.6883 | Remote Similarity | NPD7411 | Suspended |
0.6879 | Remote Similarity | NPD7075 | Discontinued |
0.6879 | Remote Similarity | NPD3749 | Approved |
0.6875 | Remote Similarity | NPD2157 | Approved |
0.6871 | Remote Similarity | NPD7037 | Approved |
0.6863 | Remote Similarity | NPD3226 | Approved |
0.686 | Remote Similarity | NPD2933 | Approved |
0.686 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.686 | Remote Similarity | NPD2934 | Approved |
0.6855 | Remote Similarity | NPD7199 | Phase 2 |
0.6853 | Remote Similarity | NPD4307 | Phase 2 |
0.6853 | Remote Similarity | NPD1558 | Phase 1 |
0.6832 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6832 | Remote Similarity | NPD6166 | Phase 2 |
0.6832 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD411 | Approved |
0.6831 | Remote Similarity | NPD1296 | Phase 2 |
0.6831 | Remote Similarity | NPD1699 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD6812 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD7985 | Registered |
0.6828 | Remote Similarity | NPD6111 | Discontinued |
0.6828 | Remote Similarity | NPD4538 | Approved |
0.6828 | Remote Similarity | NPD4536 | Approved |
0.6828 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD5177 | Phase 3 |
0.6822 | Remote Similarity | NPD5451 | Approved |
0.6821 | Remote Similarity | NPD1754 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD6599 | Discontinued |
0.6818 | Remote Similarity | NPD4380 | Phase 2 |
0.6815 | Remote Similarity | NPD3882 | Suspended |
0.6815 | Remote Similarity | NPD1651 | Approved |
0.6813 | Remote Similarity | NPD6232 | Discontinued |
0.6813 | Remote Similarity | NPD7229 | Phase 3 |
0.6806 | Remote Similarity | NPD6355 | Discontinued |
0.6803 | Remote Similarity | NPD7030 | Discontinued |
0.6803 | Remote Similarity | NPD1809 | Phase 2 |
0.68 | Remote Similarity | NPD6667 | Approved |
0.68 | Remote Similarity | NPD6666 | Approved |
Molecular Weight:   | 314.22 |
ALogP:   | 0.0246 |
MLogP:   | 3.55 |
XLogP:   | 6.205 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 29.46 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 23 |